Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2015, Article ID 184321, 15 pages
http://dx.doi.org/10.1155/2015/184321
Research Article

International Burden of Chronic Kidney Disease and Secondary Hyperparathyroidism: A Systematic Review of the Literature and Available Data

1EpidStat Institute, Ann Arbor, MI 48105, USA
2Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA
3School of Medicine, Vanderbilt University, Nashville, TN 37212, USA
4Center for Observational Research, Amgen, Inc., Thousand Oaks, CA 91320, USA
5Department of Nephrology, School of Medicine, University of Michigan, Ann Arbor, MI 48109, USA

Received 10 November 2014; Revised 22 February 2015; Accepted 5 March 2015

Academic Editor: Suresh C. Tiwari

Copyright © 2015 Elizabeth Hedgeman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie, and G. M. Chertow, “Mineral metabolism, mortality, and morbidity in maintenance hemodialysis,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2208–2218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Levey, J. Coresh, E. Balk et al., “National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” Annals of Internal Medicine, vol. 139, no. 2, pp. 137–147, 2003. View at Google Scholar
  3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, “KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD),” Kidney International Supplements, no. 113, pp. S1–S130, 2009. View at Google Scholar
  4. A. Levin, G. L. Bakris, M. Molitch et al., “Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease,” Kidney International, vol. 71, no. 1, pp. 31–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Neil, D. R. Walker, R. Sesso et al., “Gaining efficiencies: resources and demand for dialysis around the globe,” Value in Health, vol. 12, no. 1, pp. 73–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. F. De Vecchi, M. Dratwa, and M. E. Wiedemann, “Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: Costs and reimbursement/funding of ESRD therapies,” Nephrology Dialysis Transplantation, vol. 14, supplement 6, pp. 31–41, 1999. View at Google Scholar · View at Scopus
  7. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Publisher · View at Google Scholar
  9. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI), Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, National Kidney Foundation, 2002, http://www2.kidney.org/professionals/KDOQI/guidelines_bone/.
  11. International Society of Nephrology (ISN), International Society of Nephrology (ISN), http://www.theisn.org/.
  12. Google Translate [Internet], 2013, http://translate.google.com/.
  13. O. Soylemezoglu, A. Duzova, F. Yalçinkaya, T. Arinsoy, and G. Süleymanlar, “Chronic renal disease in children aged 5-18 years: a population-based survey in Turkey, the CREDIT-C study,” Nephrology Dialysis Transplantation, vol. 27, supplement 3, pp. iii146–iii151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Amato, C. Alvarez-Aguilar, R. Castañeda-Limones et al., “Prevalence of chronic kidney disease in an urban Mexican population,” Kidney International, vol. 68, pp. S11–S17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. de Nicola, C. Donfrancesco, R. Minutolo et al., “Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study,” Giornale Italiano di Nefrologia, vol. 28, no. 4, pp. 401–407, 2011. View at Google Scholar · View at Scopus
  16. P. Arora, P. Vasa, D. Brenner et al., “Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey,” CMAJ, vol. 185, no. 9, pp. E417–E423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. P. P. Varma, D. K. Raman, T. S. Ramakrishnan, P. Singh, and A. Varma, “Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India,” Nephrology Dialysis Transplantation, vol. 25, no. 9, pp. 3011–3017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. ERA-EDTA Registry, ERA-EDTA Registry Annual Report 2011, Department of Medical Informatics, Academic Medical Center, Amsterdam, The Netherlands, 2013, http://www.era-edta-reg.org/files/annualreports/pdf/AnnRep2011.pdf.
  19. The United Kingdom Renal Registry, February 2015, http://www.renalreg.com/.
  20. The Japanese Society of Dialysis and Transplant (English), 2015, http://www.jsdt.or.jp/index_e.html.
  21. S. Nakai, Y. Watanabe, I. Masakane et al., “Overview of regular dialysis treatment in Japan (as of 31 December 2011),” Therapeutic Apheresis and Dialysis, vol. 17, no. 6, pp. 567–611, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. The Korean Society of Nephrology, KSN.org, http://www.ksn.or.kr/english/.
  23. The Turkish Society of Nephrology, TSN.org, 2015, http://tsn.org.tr/en/.
  24. Canadian Institute for Health Information, Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2002 to 2011, Canadian Institute for Health Information, 2013, https://secure.cihi.ca/free_products/2013_CORR_Annua_Report_EN.pdf.
  25. U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Report No.: 2013, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2013, http://www.usrds.org/adr.aspx.
  26. “Australia and New Zealand dialysis and transplant registry,” Annual Report no. 35, ANZDATA, 2013, http://www.anzdata.org.au/anzdata/AnzdataReport/35thReport/2012_annual_report.pdf.
  27. G. Rosa-Diez, M. Gonzalez-Bedat, R. Pecoits-Filho et al., “Renal replacement therapy in Latin American end-stage renal disease,” Clinical Kidney Journal, vol. 7, no. 4, pp. 431–436, 2014. View at Google Scholar
  28. Y.-W. Ho, K.-F. Chau, B.-Y. Choy et al., “Hong Kong renal registry report 2012,” Hong Kong Journal of Nephrology, vol. 15, no. 1, pp. 28–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. G. K. Modi and V. Jha, “The incidence of end-stage renal disease in India: a population-based study,” Kidney International, vol. 70, no. 12, pp. 2131–2133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zuo, M. Wang, and Chinese Association of Blood Purification Management of Chinese Hospital Association, “Current burden and probable increasing incidence of ESRD in China,” Clinical Nephrology, vol. 74, supplement 1, pp. S20–S22, 2010. View at Google Scholar
  31. U. Frei, H.-J. Schober-Halstenberg, and QuaSi-Niere, Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2006-2007, QuaSi-Niere gGmbH, Berlin, Germany, 2008.
  32. T. Jeloka, M. Mali, A. Jhamnani, S. Konde, and V. Jadhav, “Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?” The Journal of the Association of Physicians of India, vol. 60, pp. 102–105, 2012. View at Google Scholar · View at Scopus
  33. R. B. de Oliveira, E. N. da Silva, D. M. F. Charpinel et al., “Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy,” Jornal Brasileiro de Nefrologia, vol. 33, no. 4, pp. 457–462, 2011. View at Google Scholar · View at Scopus
  34. Arbor Research Collaborative for Health, Dialysis Outcomes Practice Patterns Study (DOPPS) Practice Monitor, 2013, http://www.dopps.org/DPM/.
  35. ESRD Incidence Study Group, J. H. Stewart, M. R. E. McCredie, and S. M. Williams, “Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998–2002,” Nephrology Dialysis Transplantation, vol. 21, no. 8, pp. 2178–2183, 2006. View at Google Scholar
  36. J. H. Stewart, M. R. E. McCredie, S. M. Williams, K. J. Jager, L. Trpeski, and S. P. McDonald, “Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20–64 years in Europe, Canada and the Asia-Pacific region, 1998–2002,” Nephrology, vol. 12, no. 5, pp. 520–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. D. Lindeman, J. Tobin, and N. W. Shock, “Longitudinal studies on the rate of decline in renal function with age,” Journal of the American Geriatrics Society, vol. 33, no. 4, pp. 278–285, 1985. View at Google Scholar · View at Scopus
  38. X. J. Zhou, D. Rakheja, X. Yu, R. Saxena, N. D. Vaziri, and F. G. Silva, “The aging kidney,” Kidney International, vol. 74, no. 6, pp. 710–720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. K. Kuhlmann, M. Yoshino, and N. W. Levin, “Differences in cardiovascular mortality rates among hemodialysis patients in the United States and Japan: the importance of background cardiovascular mortality,” Hemodialysis International, vol. 8, no. 4, pp. 394–399, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. D. A. Goodkin, J. L. Bragg-Gresham, K. G. Koenig et al., “Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS),” Journal of the American Society of Nephrology, vol. 14, no. 12, pp. 3270–3277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. S. L. White, S. J. Chadban, S. Jan, J. R. Chapman, and A. Cass, “How can we achieve global equity in provision of renal replacement therapy?” Bulletin of the World Health Organization, vol. 86, no. 3, pp. 229–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-P. Lafrance, H. Cardinal, M. Leblanc et al., “Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends,” BMC Nephrology, vol. 14, no. 1, article 100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. W. G. Goodman, H. Jüppner, I. B. Salusky, and D. J. Sherrard, “Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy,” Kidney International, vol. 63, no. 1, pp. 1–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. W. M. Michels, D. C. Grootendorst, M. Verduijn, E. G. Elliott, F. W. Dekker, and R. T. Krediet, “Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 6, pp. 1003–1009, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. A. Rivera, S. Barquera, F. Campirano, I. Campos, M. Safdie, and V. Tovar, “Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity,” Public Health Nutrition, vol. 5, no. 1, pp. 113–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. United States Centers for Disease Control and Prevention, National Health and Nutrition Examination Survey (NHANES), 2013, http://www.cdc.gov/nchs/nhanes.htm.
  47. Korean National Health and Nutrition Examination Survey, 2013, https://knhanes.cdc.go.kr/.
  48. M. S. Tremblay and S. C. Gorber, “Canadian health measures survey: brief overview,” Canadian Journal of Public Health, vol. 98, no. 6, pp. 453–456, 2007. View at Google Scholar · View at Scopus
  49. P. E. Stevens, D. J. O'Donoghue, S. De Lusignan et al., “Chronic kidney disease management in the United Kingdom: NEOERICA project results,” Kidney International, vol. 72, no. 1, pp. 92–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Imai, M. Horio, T. Watanabe et al., “Prevalence of chronic kidney disease in the Japanese general population,” Clinical & Experimental Nephrology, vol. 13, no. 6, pp. 621–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Bongard, J. Dallongeville, D. Arveiler et al., “Assessment and characteristics of chronic kidney disease in France,” Annales de Cardiologie et d'Angeiologie, vol. 61, no. 4, pp. 239–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Vinhas, L. Gardete-Correia, J. M. Boavida et al., “Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: data from the PREVADIAB study,” Nephron—Clinical Practice, vol. 119, no. 1, pp. c35–c40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. A. O. González, A. de Francisco, P. Gayoso, and F. García, “Prevalence of chronic renal disease in Spain: results of the EPIRCE study,” Nefrologia, vol. 30, no. 1, pp. 78–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Zhang, F. Wang, L. Wang et al., “Prevalence of chronic kidney disease in China: a cross-sectional survey,” The Lancet, vol. 379, no. 9818, pp. 815–822, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. H.-T. Kang, J. Lee, J. A. Linton, B.-J. Park, and Y.-J. Lee, “Trends in the prevalence of chronic kidney disease in Korean adults:The Korean National Health and Nutrition Examination Survey from 1998 to 2009,” Nephrology Dialysis Transplantation, vol. 28, no. 4, pp. 927–936, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Süleymanlar, C. Uta, T. Arinsoy et al., “A population-based survey of chronic REnal disease in Turkey-the CREDIT study,” Nephrology Dialysis Transplantation, vol. 26, no. 6, pp. 1862–1871, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. Australian Institute of Health and Welfare, An Overview of Chronic Kidney Disease in Australia, 2009, Australian Institute of Health and Welfare, 2009, http://www.aihw.gov.au/.
  58. Dansk Nefrologisk Selskabs Landsregister (DNSL), Årsrapport 2012 [Danish Nephrology Registry (DNR) Annual Report 2012], 2013, http://www.nephrology.dk/%C3%85rsrapporter.htm.
  59. R. B. D. Oliveira, E. N. D. Silva, D. M. F. Charpinel et al., “Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy,” Jornal Brasileiro de Nefrologia, vol. 33, no. 4, pp. 457–462, 2011. View at Google Scholar · View at Scopus